by GlobeNewsWire | Nov 3, 2016 | Globe Newswire
EMERYVILLE, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced financial results for the quarter ended September 30, 2016. “This was a milestone quarter for the company as we prepared for and submitted our New...
by GlobeNewsWire | Nov 3, 2016 | Globe Newswire
CAMBRIDGE, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced...
by GlobeNewsWire | Nov 3, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today reported third quarter 2016 financial results. ...
by GlobeNewsWire | Nov 3, 2016 | Globe Newswire
Third quarter total revenue up 4% from a year ago to $75.1 million.Third quarter net loss of $(7.4) million, or $(0.09) per share, compared to net loss of $(11.1) million, or $(0.13) per share, in the third quarter of 2015.Third quarter Non-GAAP net loss(1) of $(1.0)...
by GlobeNewsWire | Nov 3, 2016 | Globe Newswire
CHARLOTTE, N.C., Nov. 03, 2016 (GLOBE NEWSWIRE) — Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week third fiscal quarter ended September 25, 2016. Bojangles’ also updated its annual guidance for its fiscal year 2016,...